In Fordyce, an accusation has been made against a psychiatric treatment center for children where negligence has paved the path for youth-on-youth sexual assaults, as per a lawsuit in the United States District Court in Pine Bluff. A lawsuit was filed by a couple against Millcreek Behavioral Health of Fordyce, […]
Sustainable development can’t be realized in Tanzania without a good population, that’s why the health segment has acquired a rather vital financial help from its development partner Germany to ameliorate, Information and Communications Technology (ICT) within the National Health Insurance Fund (NHIF) factors. Rendering to a report by The Citizen, […]
A Rough Sleeping allowance of £1.9 million has today, Tuesday 22 October 2019, been given to 6 projects involving partnerships between Local Authorities (LAs) and Clinical Commissioning Groups (CCGs). These 6 projects will test and analyze models that improve access to health services for people who have both mental ill-health […]
The NHS has been there for over 70 years, but some say its traditional methods need to change with the times. “A tide of technology” should be accepted, says Health Secretary Matt Hancock. In an article published in Business Reporter, Karen Livingstone, National Director of AHSN (Academic Health Science Networks), […]
Health Canada has given approval to the Neratinib for the treatment of patients with early-stage, hormone receptor (HR)–positive, HER2-overexpressed/amplified breast cancer in the extended adjuvant setting. The agent should be given to patients a year after completing trastuzumab-based adjuvant therapy. Findings from the phase 3 ExteNET trial supported the approval, […]
Reuters was told by the European start-ups that the lab-grown meat, which was introduced to the world 6 years ago in the form of a $280k hamburger, could hit supermarket shelves at $10 per patty within two years. According to the Good Food Institute market researcher, Consumers who are concerned […]
An emerging biotech firm which develops cancer metabolism-based therapies, Tyme Technologies Inc. made an announcement that its multicenter open-label Phase 2 TYME-88-Panc study analyzing SM-88 as an oral monotherapy in patients who have advanced pancreatic cancer continues to score encouraging results & a nicely-tolerated safety profile. At the European Society […]
